{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:01:49Z","timestamp":1791482509954,"version":"4.3.4"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dow University of Health Sciences","award":["DUHS\/VC\/2024\/11-04\/04"],"award-info":[{"award-number":["DUHS\/VC\/2024\/11-04\/04"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    A simple, reproducible, and green high-performance liquid chromatography (HPLC) method was developed and validated for the precise quantification of paclitaxel in plasma following an intravenous dose in patients with breast cancer. The proposed method is developed to enhance efficiency, offering significant advantages including rapid analysis, one-step extraction, low solvent consumption, and thorough validation with extensive parameters. Chromatographic analysis was performed using Schimadzu HPLC with LC solution software. Plasma proteins were precipitated using acetonitrile for efficient extraction of paclitaxel. A separation was achieved on C18 column with the mobile phase being a combination of acetonitrile and water in the combination of 65:35 (v\/v). The method exhibited excellent linearity (with a correlation coefficient of 0.9999) over the concentration range of 0.375 \u03bcg\/mL to 8 \u03bcg\/mL. The lower limit of quantification was found to be 0.375 \u03bcg\/mL. The accuracy and precision of the intra-day (96.87\u201399.65%) and inter-day (98.3\u201399.9%) assays, comply with accepted bioanalytical criteria. The recovery of paclitaxel from plasma ranged between 96.97 and 100%. Stability studies indicated that paclitaxel remained stable after 24 hours at room temperature and 4 weeks at \u221220\u00b0C. AGREE, AGREEprep, ComplexGAPI, AMVI, AMGS, and ESA tools confirmed the environmental friendliness and greenness of the proposed method. Furthermore, the method was successfully utilized in the pharmacokinetic investigation of paclitaxel in breast cancer patients. The determined values of C\n                    <jats:sub>max<\/jats:sub>\n                    were found comparable with reported values, confirming the method\u2019s suitability for clinical pharmacokinetic study.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0358891","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:48:38Z","timestamp":1791481718000},"page":"e0358891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and clinical validation of HPLC method for precise quantification of paclitaxel in plasma from breast cancer patients"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-8134","authenticated-orcid":true,"given":"Najia","family":"Rahim","sequence":"first","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"],"department":["Department of Pharmacy Practice, Dow College of Pharmacy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Shakeel","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"],"department":["Department of Pharmacy Practice, Dow College of Pharmacy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-0743","authenticated-orcid":true,"given":"Maryum","family":"Nouman","sequence":"additional","affiliation":[{"name":"Dow University Hospital","place":["Karachi, Pakistan"],"department":["Department of Medical Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Asim","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"],"department":["Dow Institute of Biological, Biochemical and Pharmaceutical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"],"department":["Dow Institute of Biological, Biochemical and Pharmaceutical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulqarnain","family":"Hassan","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences","place":["Karachi, Pakistan"],"department":["Dow Institute of Biological, Biochemical and Pharmaceutical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"pone.0358891.ref001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"M Arnold","year":"2022","journal-title":"Breast"},{"key":"pone.0358891.ref002","unstructured":"Society AC. 2025."},{"issue":"24","key":"pone.0358891.ref003","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.3390\/ijms232415619","article-title":"Natural Taxanes: From plant composition to human pharmacology and toxicity","volume":"23","author":"\u013d Ni\u017enansk\u00fd","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0358891.ref004","doi-asserted-by":"crossref","first-page":"1184472","DOI":"10.3389\/fphar.2023.1184472","article-title":"A review of FDA approved drugs and their formulations for the treatment of breast cancer","volume":"14","author":"M Chaurasia","year":"2023","journal-title":"Front Pharmacol"},{"key":"pone.0358891.ref005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1634\/theoncologist.9-suppl_2-24","article-title":"Docetaxel and paclitaxel in the treatment of breast cancer: A review of clinical experience","author":"J Crown","year":"2004","journal-title":"Oncologist"},{"issue":"30","key":"pone.0358891.ref006","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.2174\/092986709789352277","article-title":"Medicinal chemistry of paclitaxel and its analogues","volume":"16","author":"Y Fu","year":"2009","journal-title":"Curr Med Chem"},{"issue":"10","key":"pone.0358891.ref007","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ijc.22557","article-title":"Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of beta-tubulins","volume":"120","author":"S Tommasi","year":"2007","journal-title":"Int J Cancer"},{"key":"pone.0358891.ref008","first-page":"309","article-title":"Tubulin and microtubules as targets for anticancer drugs","volume":"5","author":"JA Hadfield","year":"2003","journal-title":"Prog Cell Cycle Res"},{"issue":"4","key":"pone.0358891.ref009","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1091\/mbc.10.4.947","article-title":"Taxol suppresses dynamics of individual microtubules in living human tumor cells","volume":"10","author":"AM Yvon","year":"1999","journal-title":"Mol Biol Cell"},{"issue":"6","key":"pone.0358891.ref010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.3.6.755","article-title":"Paclitaxel in cancer therapy","volume":"3","author":"TM Mekhail","year":"2002","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"pone.0358891.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193500","article-title":"A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6\u03b1-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study","volume":"13","author":"B Posocco","year":"2018","journal-title":"PLoS One"},{"key":"pone.0358891.ref012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpba.2013.12.028","article-title":"LC-MS\/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy","volume":"91","author":"MA Fern\u00e1ndez-Peralbo","year":"2014","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"pone.0358891.ref013","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1570-0232(02)00659-1","article-title":"Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma","volume":"783","author":"RA Parise","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"pone.0358891.ref014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1570-0232(02)00913-3","article-title":"Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma","volume":"785","author":"MS Alexander","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"pone.0358891.ref015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0378-4347(93)80100-I","article-title":"High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol) in human plasma","volume":"621","author":"TA Willey","year":"1993","journal-title":"J Chromatogr"},{"issue":"5","key":"pone.0358891.ref016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.17485\/ijst\/2009\/v2i5.16","article-title":"Sensitive and validated HPLC method for determination of paclitaxel in human serum","volume":"2","author":"G Rajender","year":"2009","journal-title":"Indian J Sci Technol"},{"issue":"5","key":"pone.0358891.ref017","first-page":"647","article-title":"A rapid and sensitive HPLC method for quantitation of paclitaxel in biological samples using liquid-liquid extraction and UV detection: Application to pharmacokinetics and tissues distribution study of paclitaxel loaded targeted polymeric micelles in","volume":"18","author":"M Rezazadeh","year":"2015","journal-title":"J Pharm Pharmaceut Sci"},{"issue":"3","key":"pone.0358891.ref018","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/bmc.759","article-title":"Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC-UV detection","volume":"21","author":"H Yonemoto","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"pone.0358891.ref019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6904-6-2","article-title":"High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection","volume":"6","author":"A Andersen","year":"2006","journal-title":"BMC Clin Pharmacol"},{"issue":"12","key":"pone.0358891.ref020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4155\/bio-2022-0095","article-title":"Green bioanalysis: an innovative and eco-friendly approach for analyzing drugs in biological matrices","volume":"14","author":"SN Rao Gajula","year":"2022","journal-title":"Bioanalysis"},{"key":"pone.0358891.ref021","volume-title":"Bioanalytical Method Validation; Guidance for Industry","author":"(CDER) USDoHaHSFaDACfDEaR","year":"2018"},{"key":"pone.0358891.ref022","volume-title":"ICH Harmonised guideline; bioanalytical method validation and study sample analysis-M10","author":"ICH","year":"2022"},{"issue":"12","key":"pone.0358891.ref023","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1634\/theoncologist.2010-0095","article-title":"Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumors","volume":"15","author":"AR Tan","year":"2010","journal-title":"Oncologist"},{"issue":"6","key":"pone.0358891.ref024","first-page":"599","article-title":"Clinical pharmacokinetics and pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour infusion","volume":"1","author":"T Ohtsu","year":"1995","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0358891.ref025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/annonc\/mdp315","article-title":"Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors","volume":"21","author":"WT Lim","year":"2010","journal-title":"Ann Oncol"},{"issue":"15","key":"pone.0358891.ref026","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1158\/1078-0432.CCR-18-0656","article-title":"Paclitaxel plasma concentration after the first infusion predicts treatment-limiting peripheral neuropathy","volume":"24","author":"DL Hertz","year":"2018","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"pone.0358891.ref027","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.sampre.2023.100068","article-title":"Green profile tools: Current status and future perspectives","volume":"6","author":"M Locatelli","year":"2023","journal-title":"Adv Sample Prep"},{"issue":"14","key":"pone.0358891.ref028","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness Metric Approach and Software","volume":"92","author":"F Pena-Pereira","year":"2020","journal-title":"Anal Chem"},{"key":"pone.0358891.ref029","doi-asserted-by":"crossref","first-page":"116553","DOI":"10.1016\/j.trac.2022.116553","article-title":"AGREEprep \u2013 Analytical greenness metric for sample preparation","volume":"149","author":"W Wojnowski","year":"2022","journal-title":"TrAC Trends Anal Chem"},{"issue":"21","key":"pone.0358891.ref030","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1039\/D1GC02318G","article-title":"Complementary green analytical procedure index (ComplexGAPI) and software","volume":"23","author":"J P\u0142otka-Wasylka","year":"2021","journal-title":"Green Chem"},{"issue":"4","key":"pone.0358891.ref031","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1039\/c0gc00524j","article-title":"Analytical Method Volume Intensity (AMVI): A green chemistry metric for HPLC methodology in the pharmaceutical industry","volume":"13","author":"R Hartman","year":"2011","journal-title":"Green Chem"},{"key":"pone.0358891.ref032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"A Ga\u0142uszka","year":"2012","journal-title":"TrAC Trends Anal Chem"},{"issue":"23","key":"pone.0358891.ref033","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1039\/D0GC90121K","article-title":"Correction: Making the move towards modernized greener separations: Introduction of the analytical method greenness score (AMGS) calculator","volume":"22","author":"MB Hicks","year":"2020","journal-title":"Green Chem"},{"key":"pone.0358891.ref034","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"issue":"2","key":"pone.0358891.ref035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0378-4347(95)00308-8","article-title":"Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography","volume":"674","author":"MT Huizing","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"1","key":"pone.0358891.ref036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40262-017-0563-z","article-title":"Clinical pharmacokinetics of paclitaxel monotherapy: An updated literature review","volume":"57","author":"TB Stage","year":"2018","journal-title":"Clin Pharmacokinet"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:48:47Z","timestamp":1791481727000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358891"}},"subtitle":[],"editor":[{"given":"Rajesh Kumar","family":"Singh","sequence":"first","affiliation":[{"name":"Institute of Medical Sciences, Banaras Hindu University","place":["INDIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0358891","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}